Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2025-05-22 00:00:00 ET · period of report 2025-05-20 · accession 0001048477-25-000064 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-22 | 2025-05-20 | BMRN | Bodem Barbara W. | Dir | A - Grant | $0.00 | +6,650 | 13.6K | +96% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-20 | A | A | 6,650 | $0.00 | 13,555 | D | — | — | (F1) Restricted stock units granted on May 20, 2025. Price not applicable. (F2) The Reporting Person's direct holdings have been adjusted by five shares to correct a previous clerical error. |